Regulation of epidermal keratinocytes by growth factors

Journal of Dermatological Science

Volumn 59, Issue 2, 2010, Pages 73-80

  Shirakata, Yuji ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemokine; Cytokine; Growth factor; Keratinocyte; Proliferation

Indexed keywords

ALPHA CHEMOKINE; AMPHIREGULIN; ANGIOTENSIN II; BETA CHEMOKINE; BRAIN DERIVED NEUROTROPHIC FACTOR; COLECALCIFEROL; CYTOKINE; ENDOTHELIN 1; EPIDERMAL GROWTH FACTOR; EPIREGULIN; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIN; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; STEM CELL FACTOR; THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SECRETION; DNA SYNTHESIS; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINES; CYTOKINES; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KERATINOCYTES; MICE;

EID: 77955058550     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.05.002     Document Type: Review

References (100)

1. Nickoloff B.J., Xin H., Nestle F.O., Qin J.Z. The cytokine and chemokine network in psoriasis. Clin Dermatol 2007, 25:568-573.
2. Tokura Y. Extrinsic and intrinsic types of atopic dermatitis. J Dermatol Sci 2010, 58:1-7.
3. Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003, 83:835-870.
4. Harris R.C., Chung E., Coffey R.J. EGF receptor ligands. Exp Cell Res 2003, 284:2-13.
5. Higashiyama S., Iwabuki H., Morimoto C., Hieda M., Inoue H., Matsushita N. Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands. Cancer Sci 2008, 99:214-220.
6. Jorissen R.N., Walker F., Pouliot N., Garrett T.P., Ward C.W., Burgess A.W. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 2003, 284:31-53.
7. Hashimoto K. Regulation of keratinocyte function by growth factors. J Dermatol Sci 2000, 24:S46-S50.
8. Coffey R.J., Derynck R., Wilcox J.N., Bringman T.S., Goustin A.S., Moses H.L., et al. Production and auto-induction of transforming growth factor-alpha in human keratinocytes. Nature 1987, 328:817-820.
9. Elder J.T., Fisher G.J., Lindquist P.B., Bennett G.L., Pittelkow M.R., Coffey R.J., et al. Overexpression of transforming growth factor alpha in psoriatic epidermis. Science 1989, 243:811-814.
10. Cook P.W., Pittelkow M.R., Keeble W.W., Graves-Deal R., Coffey R.J., Shipley G.D. Amphiregulin messenger RNA is elevated in psoriatic epidermis and gastrointestinal carcinomas. Cancer Res 1992, 52:3224-3227.
11. Higashiyama S., Abraham J.A., Miller J., Fiddes J.C., Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991, 251:936-939.
12. Hashimoto K., Higashiyama S., Asada H., Hashimura E., Kobayashi T., Sudo K., et al. Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J Biol Chem 1994, 269:20060-20066.
13. Zheng Y., Peng Z., Wang Y., Tan S., Xi Y., Wang G. Alteration and significance of heparin-binding epidermal-growth-factor-like growth factor in psoriatic epidermis. Dermatology 2003, 207:22-27.
14. Shirakata Y., Tokumaru S., Sayama K., Hashimoto K. Auto- and cross-induction by betacellulin in epidermal keratinocytes. J Dermatol Sci 2010, 58:162-164.
15. Piepkorn M., Predd H., Underwood R., Cook P. Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes. Arch Dermatol Res 2003, 295:93-101.
16. Shirakata Y., Kishimoto J., Tokumaru S., Yamasaki K., Hanakawa Y., Tohyama M., et al. Epiregulin, a member of the EGF family, is over-expressed in psoriatic epidermis. J Dermatol Sci 2007, 45:69-72.
17. Shirakata Y., Komurasaki T., Toyoda H., Hanakawa Y., Yamasaki K., Tokumaru S., et al. Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes. J Biol Chem 2000, 275:5748-5753.
18. Miettinen P.J., Berger J.E., Meneses J., Phung Y., Pedersen R.A., Werb Z., et al. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 1995, 376:337-341.
19. Sibilia M., Wagner E.F. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 1995, 269:234-238.
20. Threadgill D.W., Dlugosz A.A., Hansen L.A., Tennenbaum T., Lichti U., Yee D., et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 1995, 269:230-234.
21. Fowler K.J., Walker F., Alexander W., Hibbs M.L., Nice E.C., Bohmer R.M., et al. A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation. Proc Natl Acad Sci USA 1995, 92:1465-1469.
22. Murillas R., Larcher F., Conti C.J., Santos M., Ullrich A., Jorcano J.L. Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure. Embo J 1995, 14:5216-5223.
23. Sugawara K., Schneider M.R., Dahlhoff M., Kloepper J.E., Paus R. Cutaneous consequences of inhibiting EGF receptor signaling in vivo: normal hair follicle development, but retarded hair cycle induction and inhibition of adipocyte growth in Egfr(Wa5) mice. J Dermatol Sci 2010, 57:155-161.
24. Luetteke N.C., Qiu T.H., Peiffer R.L., Oliver P., Smithies O., Lee D.C. TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 1993, 73:263-278.
25. Kim I., Mogford J.E., Chao J.D., Mustoe T.A. Wound epithelialization deficits in the transforming growth factor-alpha knockout mouse. Wound Repair Regen 2001, 9:386-390.
26. Luetteke N.C., Qiu T.H., Fenton S.E., Troyer K.L., Riedel R.F., Chang A., et al. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 1999, 126:2739-2750.
27. Shirasawa S., Sugiyama S., Baba I., Inokuchi J., Sekine S., Ogino K., et al. Dermatitis due to epiregulin deficiency and a critical role of epiregulin in immune-related responses of keratinocyte and macrophage. Proc Natl Acad Sci USA 2004, 101:13921-13926.
28. Shirakata Y., Kimura R., Nanba D., Iwamoto R., Tokumaru S., Morimoto C., et al. Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing. J Cell Sci 2005, 118:2363-2370.
29. Dominey A.M., Wang X.J., King L.E., Nanney L.B., Gagne T.A., Sellheyer K., et al. Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. Cell Growth Differ 1993, 4:1071-1082.
30. Cook P.W., Piepkorn M., Clegg C.H., Plowman G.D., DeMay J.M., Brown J.R., et al. Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. J Clin Invest 1997, 100:2286-2294.
31. Mak K.K., Chan S.Y. Epidermal growth factor as a biologic switch in hair growth cycle. J Biol Chem 2003, 278:26120-26126.
32. Schneider M.R., Antsiferova M., Feldmeyer L., Dahlhoff M., Bugnon P., Hasse S., et al. Betacellulin regulates hair follicle development and hair cycle induction and enhances angiogenesis in wounded skin. J Invest Dermatol 2008, 128:1256-1265.
33. Eswarakumar V.P., Lax I., Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 2005, 16:139-149.
34. Sogabe Y., Abe M., Yokoyama Y., Ishikawa O. Basic fibroblast growth factor stimulates human keratinocyte motility by Rac activation. Wound Repair Regen 2006, 14:457-462.
35. Finch P.W., Rubin J.S., Miki T., Ron D., Aaronson S.A. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 1989, 245:752-755.
36. Werner S. Keratinocyte growth factor: a unique player in epithelial repair processes. Cytokine Growth Factor Rev 1998, 9:153-165.
37. Marchese C., Chedid M., Dirsch O.R., Csaky K.G., Santanelli F., Latini C., et al. Modulation of keratinocyte growth factor and its receptor in reepithelializing human skin. J Exp Med 1995, 182:1369-1376.
38. Guo L., Degenstein L., Fuchs E. Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev 1996, 10:165-175.
39. Sato C., Tsuboi R., Shi C.M., Rubin J.S., Ogawa H. Comparative study of hepatocyte growth factor/scatter factor and keratinocyte growth factor effects on human keratinocytes. J Invest Dermatol 1995, 104:958-963.
40. Gohda E., Tsubouchi H., Nakayama H., Hirono S., Sakiyama O., Takahashi K., et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988, 81:414-419.
41. Giordano S., Di Renzo M.F., Narsimhan R.P., Cooper C.S., Rosa C., Comoglio P.M. Biosynthesis of the protein encoded by the c-met proto-oncogene. Oncogene 1989, 4:1383-1388.
42. Matsumoto K., Hashimoto K., Yoshikawa K., Nakamura T. Marked stimulation of growth and motility of human keratinocytes by hepatocyte growth factor. Exp Cell Res 1991, 196:114-120.
43. Tokumaru S., Sayama K., Yamasaki K., Shirakata Y., Hanakawa Y., Yahata Y., et al. SOCS3/CIS3 negative regulation of STAT3 in HGF-induced keratinocyte migration. Biochem Biophys Res Commun 2005, 327:100-105.
44. Botchkarev V.A., Yaar M., Peters E.M., Raychaudhuri S.P., Botchkareva N.V., Marconi A., et al. Neurotrophins in skin biology and pathology. J Invest Dermatol 2006, 126:1719-1727.
45. Segal R.A. Selectivity in neurotrophin signaling: theme and variations. Annu Rev Neurosci 2003, 26:299-330.
46. Marconi A., Terracina M., Fila C., Franchi J., Bonte F., Romagnoli G., et al. Expression and function of neurotrophins and their receptors in cultured human keratinocytes. J Invest Dermatol 2003, 121:1515-1521.
47. Di Marco E., Mathor M., Bondanza S., Cutuli N., Marchisio P.C., Cancedda R., et al. Nerve growth factor binds to normal human keratinocytes through high and low affinity receptors and stimulates their growth by a novel autocrine loop. J Biol Chem 1993, 268:22838-22846.
48. Pincelli C., Marconi A. Autocrine nerve growth factor in human keratinocytes. J Dermatol Sci 2000, 22:71-79.
49. Tavakkol A., Elder J.T., Griffiths C.E., Cooper K.D., Talwar H., Fisher G.J., et al. Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. J Invest Dermatol 1992, 99:343-349.
50. Sadagurski M., Yakar S., Weingarten G., Holzenberger M., Rhodes C.J., Breitkreutz D., et al. Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation. Mol Cell Biol 2006, 26:2675-2687.
51. Imokawa G., Yada Y., Kimura M., Morisaki N. Granulocyte/macrophage colony-stimulating factor is an intrinsic keratinocyte-derived growth factor for human melanocytes in UVA-induced melanosis. Biochem J 1996, 313(Pt 2):625-631.
52. Kawada A., Hiruma M., Noguchi H., Ishibashi A., Motoyoshi K., Kawada I. Granulocyte and macrophage colony-stimulating factors stimulate proliferation of human keratinocytes. Arch Dermatol Res 1997, 289:600-602.
53. Mann A., Breuhahn K., Schirmacher P., Blessing M. Keratinocyte-derived granulocyte-macrophage colony stimulating factor accelerates wound healing: stimulation of keratinocyte proliferation, granulation tissue formation, and vascularization. J Invest Dermatol 2001, 117:1382-1390.
54. Fang Y., Gong S.J., Xu Y.H., Hambly B.D., Bao S. Impaired cutaneous wound healing in granulocyte/macrophage colony-stimulating factor knockout mice. Br J Dermatol 2007, 157:458-465.
55. Bagnato A., Venuti A., Di Castro V., Marcante M.L. Identification of the ETA receptor subtype that mediates endothelin induced autocrine proliferation of normal human keratinocytes. Biochem Biophys Res Commun 1995, 209:80-86.
56. Tsuboi R., Sato C., Shi C.M., Nakamura T., Sakurai T., Ogawa H. Endothelin-1 acts as an autocrine growth factor for normal human keratinocytes. J Cell Physiol 1994, 159:213-220.
57. Yahata Y., Shirakata Y., Tokumaru S., Yang L., Dai X., Tohyama M., et al. A novel function of angiotensin II in skin wound healing, Induction of fibroblast and keratinocyte migration by angiotensin II via heparin-binding epidermal growth factor (EGF)-like growth factor-mediated EGF receptor transactivation. J Biol Chem 2006, 281:13209-13216.
58. Kataoka H. EGFR ligands and their signaling scissors, ADAMs, as new molecular targets for anticancer treatments. J Dermatol Sci 2009, 56:148-153.
59. Tokumaru S., Sayama K., Shirakata Y., Komatsuzawa H., Ouhara K., Hanakawa Y., et al. Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J Immunol 2005, 175:4662-4668.
60. Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998, 67:753-791.
61. Ihn H. Autocrine TGF-beta signaling in the pathogenesis of systemic sclerosis. J Dermatol Sci 2008, 49:103-113.
62. Miyazono K., ten Dijke P., Heldin C.H. TGF-beta signaling by Smad proteins. Adv Immunol 2000, 75:115-157.
63. Nakao A., Afrakhte M., Moren A., Nakayama T., Christian J.L., Heuchel R., et al. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 1997, 389:631-635.
64. Imamura T., Takase M., Nishihara A., Oeda E., Hanai J., Kawabata M., et al. Smad6 inhibits signalling by the TGF-beta superfamily. Nature 1997, 389:622-626.
65. Pietenpol J.A., Holt J.T., Stein R.W., Moses H.L. Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc Natl Acad Sci USA 1990, 87:3758-3762.
66. Matsumoto K., Hashimoto K., Hashiro M., Yoshimasa H., Yoshikawa K. Modulation of growth and differentiation in normal human keratinocytes by transforming growth factor-beta. J Cell Physiol 1990, 145:95-101.
67. Midorikawa K., Sayama K., Shirakata Y., Hanakawa Y., Sun L., Hashimoto K. Expression of vitamin D receptor in cultured human keratinocytes and fibroblasts is not altered by corticosteroids. J Dermatol Sci 1999, 21:8-12.
68. Reichrath J., Munssinger T., Kerber A., Rochette-Egly C., Chambon P., Bahmer F.A., et al. In situ detection of retinoid-X receptor expression in normal and psoriatic human skin. Br J Dermatol 1995, 133:168-175.
69. Matsumoto K., Hashimoto K., Nishida Y., Hashiro M., Yoshikawa K. Growth-inhibitory effects of 1, 25-dihydroxyvitamin D3 on normal human keratinocytes cultured in serum-free medium. Biochem Biophys Res Commun 1990, 166:916-923.
70. Shirakata Y., Ueno H., Hanakawa Y., Kameda K., Yamasaki K., Tokumaru S., et al. TGF-beta is not involved in early phase growth inhibition of keratinocytes by 1alpha, 25(OH)2vitamin D3. J Dermatol Sci 2004, 36:41-50.
71. Takahashi H., Ibe M., Kinouchi M., Ishida-Yamamoto A., Hashimoto Y., Iizuka H. Similarly potent action of 1,25-dihydroxyvitamin D3 and its analogues, tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation. J Dermatol Sci 2003, 31:21-28.
72. Nickoloff B.J., Mahrle G., Morhenn V. Ultrastructural effects of recombinant gamma-interferon on cultured human keratinocytes. Ultrastruct Pathol 1986, 10:17-21.
73. Karlsson T., Vahlquist A., Torma H. Keratinocyte differentiation induced by calcium, phorbol ester or interferon-gamma elicits distinct changes in the retinoid signalling pathways. J Dermatol Sci 2010, 57:207-213.
74. Saunders N.A., Jetten A.M. Control of growth regulatory and differentiation-specific genes in human epidermal keratinocytes by interferon gamma, Antagonism by retinoic acid and transforming growth factor beta 1. J Biol Chem 1994, 269:2016-2022.
75. Uchi H., Terao H., Koga T., Furue M. Cytokines and chemokines in the epidermis. J Dermatol Sci 2000, 24(Suppl. 1):S29-S38.
76. Ansel J., Perry P., Brown J., Damm D., Phan T., Hart C., et al. Cytokine modulation of keratinocyte cytokines. J Invest Dermatol 1990, 94:101S-107S.
77. Grabbe J., Welker P., Dippel E., Czarnetzki B.M. Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch Dermatol Res 1994, 287:78-84.
78. Shirakata Y., Tokumaru S., Yamasaki K., Sayama K., Hashimoto K. So-called biological dressing effects of cultured epidermal sheets are mediated by the production of EGF family, TGF-beta and VEGF. J Dermatol Sci 2003, 32:209-215.
79. Detmar M. The role of VEGF and thrombospondins in skin angiogenesis. J Dermatol Sci 2000, 24(Suppl 1):S78-84.
80. Streit M., Riccardi L., Velasco P., Brown L.F., Hawighorst T., Bornstein P., et al. Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc Natl Acad Sci USA 1999, 96:14888-14893.
81. Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001, 104:487-501.
82. Kock A., Schwarz T., Kirnbauer R., Urbanski A., Perry P., Ansel J.C., et al. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 1990, 172:1609-1614.
83. Bashir M.M., Sharma M.R., Werth V.P. TNF-alpha production in the skin. Arch Dermatol Res 2009, 301:87-91.
84. Trefzer U., Brockhaus M., Lotscher H., Parlow F., Budnik A., Grewe M., et al. The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiation. J Clin Invest 1993, 92:462-470.
85. Li H., Lin X. Positive and negative signaling components involved in TNFalpha-induced NF-kappaB activation. Cytokine 2008, 41:1-8.
86. Vanden Berghe W., Plaisance S., Boone E., De Bosscher K., Schmitz M.L., Fiers W., et al. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J Biol Chem 1998, 273:3285-3290.
87. Koo J., Khera P. Update on the mechanisms and efficacy of biological therapies for psoriasis. J Dermatol Sci 2005, 38:75-87.
88. Grone A. Keratinocytes and cytokines. Vet Immunol Immunopathol 2002, 88:1-12.
89. Kunz S., Wolk K., Witte E., Witte K., Doecke W.D., Volk H.D., et al. Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs. Exp Dermatol 2006, 15:991-1004.
90. Tohyama M., Hanakawa Y., Shirakata Y., Dai X., Yang L., Hirakawa S., et al. IL-17 and IL-22 mediate IL-20 subfamily cytokine production in cultured keratinocytes via increased IL-22 receptor expression. Eur J Immunol 2009, 39:2779-2788.
91. Yawalkar N., Tscharner G.G., Hunger R.E., Hassan A.S. Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis. J Dermatol Sci 2009, 54:99-105.
92. Kanda N., Watanabe S. Suppressive effects of antimycotics on tumor necrosis factor-alpha-induced CCL27, CCL2, and CCL5 production in human keratinocytes. Biochem Pharmacol 2006, 72:463-473.
93. Lee B.S., Shim S.M., Heo J., Pae H.O., Seo B.Y., Han S.Y., et al. Wogonin suppresses TARC expression induced by mite antigen via heme oxygenase 1 in human keratinocytes, Suppressive effect of wogonin on mite antigen-induced TARC expression. J Dermatol Sci 2007, 46:31-40.
94. Nishi N., Yamamoto S., Ou W., Muro E., Inada Y., Hamasaki Y. Enhanced CCL26 production by IL-4 through IFN-gamma-induced upregulation of type 1 IL-4 receptor in keratinocytes. Biochem Biophys Res Commun 2008, 376:234-240.
95. Ohara H., Saito R., Hirakawa S., Shimada M., Mano N., Okuyama R., et al. Gene expression profiling defines the role of ATP-exposed keratinocytes in skin inflammation. J Dermatol Sci 2010.
96. Sugaya M., Nakamura K., Mitsui H., Takekoshi T., Saeki H., Tamaki K. Human keratinocytes express fractalkine/CX3CL1. J Dermatol Sci 2003, 31:179-187.
97. Tarutani M., Imai Y., Yasuda K., Tsutsui H., Nakanishi K., Yamanishi K. Neutrophil-dominant psoriasis-like skin inflammation induced by epidermal-specific expression of Raf in mice. J Dermatol Sci 2010, 58:28-35.
98. Tohyama M., Sayama K., Komatsuzawa H., Hanakawa Y., Shirakata Y., Dai X., et al. CXCL16 is a novel mediator of the innate immunity of epidermal keratinocytes. Int Immunol 2007, 19:1095-1102.
99. Tohyama M., Shirakara Y., Yamasaki K., Sayama K., Hashimoto K. Differentiated keratinocytes are responsible for TNF-alpha regulated production of macrophage inflammatory protein 3alpha/CCL20, a potent chemokine for Langerhans cells. J Dermatol Sci 2001, 27:130-139.
100. Tsuda T., Tohyama M., Yamasaki K., Shirakata Y., Yahata Y., Tokumaru S., et al. Lack of evidence for TARC/CCL17 production by normal human keratinocytes in vitro. J Dermatol Sci 2003, 31:37-42.